New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
June 2, 2014
04:55 EDTCFN, CFN, CFN, JAZZ, JAZZ, JAZZ, RMD, RMD, RMD, VNDA, VNDA, VNDA, XNPT, XNPT, XNPTAssociated Professional Sleep Societies to hold annual meeting
28th Annual SLEEP Meeting is being held in Minneapolis on May 31-June 4.
News For CFN;JAZZ;RMD;VNDA;XNPT From The Last 14 Days
Check below for free stories on CFN;JAZZ;RMD;VNDA;XNPT the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
July 28, 2014
11:36 EDTJAZZCANbridge Life Sciences and EUSA Pharma form agreement to commercialize Caphosol
CANbridge Life Sciences has entered into an exclusive partnership with EUSA Pharma, a Jazz Pharmaceuticals company, to commercialize Caphosol® in China. Under the terms of the agreement, CANbridge obtains exclusive rights to commercialize Caphosol in China, where over 3.5M new cancer cases are diagnosed each year, and there is little in the way of a standard adjunct therapy to treat oral mucositis. Caphosol is a prescription medical device, approved in the United States and European Union, designed to moisten, lubricate and clean the oral cavity including the mucosa of the mouth, tongue and oropharynx.
08:02 EDTRMDResMed receives permanent injuction against APEX in Germany
Subscribe for More Information
July 23, 2014
08:29 EDTJAZZJazz Pharmaceutical initiated with a Buy at Buckingham
Target $215.
08:10 EDTJAZZDeutsche Bank hosts an analyst Specialty Pharma/Industry conference call
Subscribe for More Information
July 22, 2014
16:09 EDTJAZZJazz Pharmaceuticals initiated with a Buy at Deutsche Bank
Subscribe for More Information
09:29 EDTCFNFDA sends warning letter to CareFusion after plant inspection
Subscribe for More Information
July 21, 2014
08:15 EDTRMDITC rules redesigned APEX humidifier infringes ResMed patents
An ITC ruling issued Friday held that, despite a redesign of its iCH CPAP device, Taiwanese device manufacturer APEX continues to infringe ResMed patents in its humidification. The original ITC action filed by ResMed in March 2013 asserted patent infringement by four products: APEX iCH and XT Fit CPAP humidifiers, the WiZARD 220 full face mask, and the WiZARD 210 nasal mask. In July 2013, APEX agreed to entry of an order prohibiting it from infringing ResMed's patents. And as a result, APEX has been banned from selling infringing products in the United States. APEX then redesigned its products and sought a ruling that it had avoided ResMed's patents. In this new ruling, the full commission held that the APEX iCH humidifier continues to infringe. As a result, APEX should continue to be banned from selling the iCH humidifier in the United States. The redesigned APEX XT Fit was found not to infringe. But APEX's expert stated that the redesigned humidifiers compromised on functionality and performance. The redesigned WiZARD 220 full face mask – which now has a fused elbow instead of the more desirable detachable elbow -- was found not to infringe on ResMed patents. Again, APEX's expert noted that the redesigned masks sacrificed functional advantages present in the ResMed products. Finally, APEX chose to withdraw its redesigned WiZARD 210 nasal mask from these proceedings, so the July 2013 order remains in place as to that product.
July 17, 2014
10:00 EDTJAZZOn The Fly: Analyst Initiation Summary
Subscribe for More Information
08:34 EDTVNDAVanda requests award of $539M in proceedings with Novartis
Subscribe for More Information
July 16, 2014
17:22 EDTJAZZJazz Pharmaceuticals initiated with a Neutral at SunTrust
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use